Lisa Kachnic named chair of Columbia Department of Radiation Oncology, chief of Radiation Oncology Service at NY-Presbyterian/Columbia University Irving Medical Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Lisa Kachnic was named chair of the Department of Radiation Oncology at the Columbia University Vagelos College of Physicians and Surgeons and chief of the radiation oncology service at New York-Presbyterian/Columbia University Irving Medical Center effective Sept. 1. She will also serve as associate director for Cancer Network Strategy in the Herbert Irving Comprehensive Cancer Center.

Kachnic is currently a professor and chair of the Department of Radiation Oncology at the Vanderbilt University School of Medicine. She previously served on the radiation oncology faculty at Massachusetts General Hospital and Boston University School of Medicine. She is a fellow of the American Society for Radiation Oncology.

A past president and current governor of the American Board of Radiology, Kachnic is the vice chair of the radiation oncology committee and co-chair of the ano-rectal subcommittee for the SWOG Cancer Research Network research base, where she serves as the multi-modality executive officer. Kachnic is also the chair of the NRG Oncology, NCI Community Oncology Research Program’s Cancer Control and Prevention Division, and is involved in NRG Oncology’s GI strategic committee.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login